Comparing effectiveness of Centchroman and Tamoxifen in mastalgia: a randomised control trial
Phase 4
Completed
- Conditions
- Health Condition 1: R52- Pain, unspecified
- Registration Number
- CTRI/2021/01/030206
- Lead Sponsor
- AIIMS Bhubaneswar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 56
Inclusion Criteria
breast pain for more than 3 months
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method breast painTimepoint: 1month, 2month, 3 month and 6th month
- Secondary Outcome Measures
Name Time Method Recurrence of SymptomsTimepoint: 6 months